semaglutide patent expiration 2031 The Heavy Price of GLP-1 Drugs – I-MAK Looming GLP-1 drug patent expirations

[6] [7] These proposed complementary mechanisms are supported by early-phase human data, though the precise contribution of each receptor pathway in clinical practice has not yet been fully established

Phase 2 obesity trial (NEJM 2023) The landmark study published in the New England Journal of Medicine tested retatrutide in adults with obesity over 48 weeks

Lixisenatide for type 2 diabetes mellitus

Take 3 oral strips daily

This mechanism stimulates insulin release and slows gastric emptying

Clinical trials have demonstrated that patients lost an average of 15 to 20 percent of their body weight over a 72-week period